Steris Stock News

Despite a bottom line beat in its fiscal Q3 2022 results, shares of Steris are unchanged in after-hours trading.

Steris press release (STE): Q3 Non-GAAP EPS of $2.12 beats by $0.16.Revenue of $1.2B (+48.3% Y/Y) in-line.FY22 Guidance:The Company is updating its expectations for fiscal 2022

DUBLIN, IRELAND, Feb. 08, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 third quarter ended December 31, 2021. Revenue as reported for the quarter increased 49% to $1.2 billion compared with $808.9 million in the third quarter of fiscal 2021. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 9% for the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Mr. David Dvorak, previously the President and CEO of Zimmer Biomet, brings a 25+ year proven track record of executive leadership, operating experience, and board memberships Dr. Gregory Berk joins with 30+ years of medical experience with oncology expertise in clinical trials, drug development, and regulatory strategy in both industry and academia GARDEN CITY, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR ), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced the appointments of Mr. David Dvorak and Dr. Gregory Berk to Beyond Cancer''s Board of Directors. Following these appointments, the Beyond Cancer Board of Directors will be comprised of six members with no further additions planned.

There are medical emergency times when both a National Emergency and a Personal Emergency must have attention. People skills, facilities, time will be shared to preserve life. Easiest to picture is a

Steris (NYSE:STE) declares $0.43/share quarterly dividend, in line with previous.Forward yield 0.77%Payable March 24; for shareholders of record Feb. 25; ex-div Feb.

DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quart

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Investors are optimistic about STERIS' (STE) strong segmental performance and bullish 2022 outlook.

Strong segmental performances are driving the top line for STERIS (STE).

Steris Plc (STE) shares closed today at 1.3% below its 52 week high of $248.30, giving the company a market cap of $24B. The stock is currently up 0.7% year-to-date, up 31.1% over the past 12 months, and up 278.7% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 9.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -89.5% The company's stock price performance over the past 12 months beats the peer average by 68.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 211.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Steris Plc (STE) shares closed today at 0.3% below its 52 week high of $245.82, giving the company a market cap of $24B. The stock is currently up 30.4% year-to-date, up 32.7% over the past 12 months, and up 284.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 22.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 77.8% The company's stock price performance over the past 12 months beats the peer average by 83.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 214.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.